RESPIRI LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.037 AUD | +8.82% |
|
+19.35% | +23.33% |
| May. 09 | Transcript : Respiri Limited - Special Call | |
| Apr. 30 | Respiri to Raise AU$1.6 Million via Placement | MT |
Presenter SpeechMatthew Liddelow (Executives)Thanks, everyone, for standing by, and welcome to...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Respiri Limited is an Australia-based e-health software as a service company that supports respiratory health management. It is engaged in research, development and commercialization of medical devices, and the development of mobile health applications. Its Wheezo technology is a breath sensor (medical device) that works with the respiri mobile applications (patient user interface) to record and track wheeze. Wheezo is a smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use. The asthma management platform also facilitates the sharing of data with caregivers, physicians and other health care professionals. Wheezo is used to detect and record abnormal breath sounds (continuous adventitious breath sounds) in the windpipe (trachea), reported as WheezeRate in adults and children for more than two years. It also offers connected care solutions for management of people living with chronic diseases.
Calendar
2024-08-27
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +23.33% | 26.21M | |
| +12.15% | 227B | |
| +14.90% | 197B | |
| +18.22% | 141B | |
| +29.15% | 110B | |
| +0.53% | 64.15B | |
| +16.92% | 53.72B | |
| +6.33% | 51.75B | |
| +10.93% | 45.2B | |
| +5.87% | 37.37B |
- Stock Market
- Equities
- RSH Stock
- News Respiri Limited
- Transcript : Respiri Limited - Shareholder/Analyst Call
